The evidence-graded clinical reference for human peptide therapeutics.
PeptideVox exists because the peptide field is loud, fast-moving, and thin on rigor. For every compound, the marketing runs years ahead of the human evidence — and the reader in the middle of a decision is left to sort hypothesis from finding alone. Our job is to document each compound like a lab spec sheet: graded evidence, sourced dosing, mechanism, and safety, in plain language, with every claim linked to a real study.
We are editorially independent and we do not sell compounds. We grade honestly — including the honest "we don't know yet" — and we put safety, contraindications, and regulatory status front and center. No hype. No affiliate spin in the science.
Every claim is graded A–D (or honestly marked "preliminary/unclear") and linked to a real, primary source. A compound earns a higher grade only with stronger human data — replicated RCTs or regulatory approval — never with louder marketing. We would rather say "we don't know yet" than inflate weak data.
Every monograph is reviewed by a credentialed clinician (MD or PharmD) before publication. The reviewer and the date of last review are stated on the page, so you can see who checked the work and when.
We cite primary literature — PubMed-indexed studies, regulatory filings, and published trials — and we never fabricate a study or a result. References are tagged by study type (RCT, meta-analysis, animal, in-vitro, regulatory) so you can weigh the strength yourself.
PeptideVox does not sell compounds and does not source them for readers. Disclaimers, contraindications, and regulatory status are prominent, and high-risk compounds carry explicit warnings. When we get something wrong, we fix it and say so — email editor@peptidevox.com.
Every monograph is vetted by a credentialed clinician (MD or PharmD) before it publishes, drawing on internal medicine, endocrinology, clinical pharmacology, and sports medicine. The reviewing clinician and the date of last review appear on each page, so you can see who checked the work and when.
PeptideVox is an independent, evidence-graded clinical reference for human peptide therapeutics. We turn the sprawling, hype-prone peptide field into clear, source-cited monographs you can actually trust — for clinicians, researchers, and rigorous self-directed readers.
Each compound carries a grade from A (replicated human RCTs or regulatory approval) down to D (minimal or no human data), plus an honest "preliminary/unclear" mark where the picture is genuinely unsettled. The grade reflects the strength of the published human evidence — not popularity, marketing, or anecdote.
No. PeptideVox does not sell, source, or facilitate the acquisition of any compound. We are an evidence reference, not a vendor. Many compounds we document are not FDA-approved and are sold only as research chemicals labeled "not for human use."
Every monograph is reviewed by a credentialed clinician (MD or PharmD) before publication, and the reviewer and last-reviewed date are shown on each page. Our reviewer panel spans internal medicine, endocrinology, clinical pharmacology, and sports medicine.
Accuracy is the whole point. If you spot an error, email editor@peptidevox.com with the page and the specific claim — see our Corrections Policy for how we review and label changes. Subscribe to The Evidence Brief for one evidence-graded brief each week, free.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.